• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺酶抑制蛋白(BLIP)的结构域间灵活性和界面完整性调节其与A类β-内酰胺酶的结合。

Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases.

作者信息

Huang Liwen, So Pui-Kin, Chen Yu Wai, Leung Yun-Chung, Yao Zhong-Ping

机构信息

State Key Laboratory of Chemical Biology and Drug Discovery, Research Institute for Future Food and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region, China; State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation) and Shenzhen Key Laboratory of Food Biological Safety Control, Shenzhen Research Institute of The Hong Kong Polytechnic University, Shenzhen, China.

State Key Laboratory of Chemical Biology and Drug Discovery, Research Institute for Future Food and Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong Special Administrative Region, China.

出版信息

J Biol Chem. 2021 Aug;297(2):100980. doi: 10.1016/j.jbc.2021.100980. Epub 2021 Jul 21.

DOI:10.1016/j.jbc.2021.100980
PMID:34302811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8363833/
Abstract

β-Lactamase inhibitory protein (BLIP) consists of a tandem repeat of αβ domains conjugated by an interdomain loop and can effectively bind and inactivate class A β-lactamases, which are responsible for resistance of bacteria to β-lactam antibiotics. The varied ability of BLIP to bind different β-lactamases and the structural determinants for significant enhancement of BLIP variants with a point mutation are poorly understood. Here, we investigated the conformational dynamics of BLIP upon binding to three clinically prevalent class A β-lactamases (TEM1, SHV1, and PC1) with dissociation constants between subnanomolar and micromolar. Hydrogen deuterium exchange mass spectrometry revealed that the flexibility of the interdomain region was significantly suppressed upon strong binding to TEM1, but was not significantly changed upon weak binding to SHV1 or PC1. E73M and K74G mutations in the interdomain region improved binding affinity toward SHV1 and PC1, respectively, showing significantly increased flexibility of the interdomain region compared to the wild-type and favorable conformational changes upon binding. In contrast, more rigidity of the interfacial loop 135-145 was observed in these BLIP mutants in both free and bound states. Consistently, molecular dynamics simulations of BLIP exhibited drastic changes in the flexibility of the loop 135-145 in all complexes. Our results indicated for the first time that higher flexibility of the interdomain linker, as well as more rigidity of the interfacial loop 135-145, could be desirable determinants for enhancing inhibition of BLIP to class A β-lactamases. Together, these findings provide unique insights into the design of enhanced inhibitors.

摘要

β-内酰胺酶抑制蛋白(BLIP)由通过结构域间环连接的αβ结构域串联重复组成,能够有效结合并灭活A类β-内酰胺酶,而这类酶会导致细菌对β-内酰胺抗生素产生耐药性。目前对于BLIP结合不同β-内酰胺酶的能力差异以及单点突变显著增强BLIP变体的结构决定因素了解甚少。在此,我们研究了BLIP与三种临床常见的A类β-内酰胺酶(TEM1、SHV1和PC1)结合时的构象动力学,其解离常数在亚纳摩尔至微摩尔之间。氢氘交换质谱显示,与TEM1强结合时,结构域间区域的灵活性显著受到抑制,但与SHV1或PC1弱结合时则无显著变化。结构域间区域的E73M和K74G突变分别提高了对SHV1和PC1的结合亲和力,与野生型相比,结构域间区域的灵活性显著增加,且结合时构象变化有利。相反,在这些BLIP突变体的游离态和结合态中均观察到界面环135 - 145的刚性增加。同样,BLIP的分子动力学模拟显示,在所有复合物中,环135 - 145的灵活性都发生了剧烈变化。我们的结果首次表明,结构域间连接子更高的灵活性以及界面环135 - 145更高的刚性,可能是增强BLIP对A类β-内酰胺酶抑制作用的理想决定因素。总之,这些发现为增强抑制剂的设计提供了独特的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/af0a652e370d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/6091accca6bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/5206d830b96a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/b8303fa12d39/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/32ac9b6eb782/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/af0a652e370d/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/6091accca6bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/5206d830b96a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/b8303fa12d39/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/32ac9b6eb782/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13b5/8363833/af0a652e370d/gr5.jpg

相似文献

1
Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases.β-内酰胺酶抑制蛋白(BLIP)的结构域间灵活性和界面完整性调节其与A类β-内酰胺酶的结合。
J Biol Chem. 2021 Aug;297(2):100980. doi: 10.1016/j.jbc.2021.100980. Epub 2021 Jul 21.
2
Conformational Dynamics of the Helix 10 Region as an Allosteric Site in Class A β-Lactamase Inhibitory Binding.A10 螺旋区构象动力学作为 A 类β-内酰胺酶抑制结合的别构位点。
J Am Chem Soc. 2020 Aug 12;142(32):13756-13767. doi: 10.1021/jacs.0c04088. Epub 2020 Aug 3.
3
Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.从宽泛到精准的工程设计:一种专门结合并检测KPCβ-内酰胺酶的β-内酰胺酶抑制蛋白(BLIP)变体的设计
ACS Infect Dis. 2016 Dec 9;2(12):969-979. doi: 10.1021/acsinfecdis.6b00160. Epub 2016 Oct 26.
4
Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.鉴定出一种β-内酰胺酶抑制蛋白变体,它是金黄色葡萄球菌 PC1β-内酰胺酶的有效抑制剂。
J Mol Biol. 2011 Mar 11;406(5):730-44. doi: 10.1016/j.jmb.2011.01.014. Epub 2011 Jan 13.
5
Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.β-内酰胺酶抑制蛋白-II(BLIP-II)与 A 类β-内酰胺酶之间紧密相互作用的结合力分析。
J Biol Chem. 2011 Sep 16;286(37):32723-35. doi: 10.1074/jbc.M111.265058. Epub 2011 Jul 20.
6
Systematic substitutions at BLIP position 50 result in changes in binding specificity for class A β-lactamases.对BLIP第50位进行系统性取代会导致对A类β-内酰胺酶的结合特异性发生变化。
BMC Biochem. 2017 Mar 6;18(1):2. doi: 10.1186/s12858-017-0077-1.
7
Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.SHV-1β-内酰胺酶-β-内酰胺酶抑制剂蛋白界面的结构与计算表征
J Biol Chem. 2006 Sep 8;281(36):26745-53. doi: 10.1074/jbc.M603878200. Epub 2006 Jun 29.
8
Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein.通过使用β-内酰胺酶抑制蛋白来解决由 A 类β-内酰胺酶引起的抗生素耐药性。
Int J Mol Sci. 2018 Jul 30;19(8):2222. doi: 10.3390/ijms19082222.
9
Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.SHV-1β-内酰胺酶/β-内酰胺酶抑制剂蛋白界面的计算重新设计。
J Mol Biol. 2008 Oct 24;382(5):1265-75. doi: 10.1016/j.jmb.2008.05.051. Epub 2008 May 29.
10
BLIP-II Employs Differential Hotspot Residues To Bind Structurally Similar Staphylococcus aureus PBP2a and Class A β-Lactamases.BLIP-II利用差异热点残基结合结构相似的金黄色葡萄球菌PBP2a和A类β-内酰胺酶。
Biochemistry. 2017 Feb 28;56(8):1075-1084. doi: 10.1021/acs.biochem.6b00978. Epub 2017 Feb 16.

引用本文的文献

1
Computational exploration of molecular flexibility and interaction of meropenem analogs with the active site of oxacillinase-23 in .美罗培南类似物与23型苯唑西林酶活性位点的分子柔性及相互作用的计算探索
Front Chem. 2023 Feb 23;11:1090630. doi: 10.3389/fchem.2023.1090630. eCollection 2023.